ロード中...
Early Outcomes with Durable Left Ventricular Assist Device Replacement Utilizing the Heartmate III
BACKGROUND: Heartmate III (HM3) Left Ventricular Assist Device (LVAD) (Abbott Inc, Chicago IL) is a fully magnetically levitated centrifugal implantable pump used to treat chronic heart failure patients. The MOMENTUM trial demonstrated that patients treated with the HM3 experienced reduced need for...
保存先:
| 出版年: | J Thorac Cardiovasc Surg |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7325332/ https://ncbi.nlm.nih.gov/pubmed/31740114 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtcvs.2019.09.151 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|